{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-042912","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.415252+00:00","generated_at":"2026-05-30T09:33:00.696504+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Aspira Women's Health presents pipeline status overview; no specific data in filing","bullets":["Slide deck provided on October 29, 2024 covers product pipeline but full content is not included in the 8-K.","No financial figures, clinical results, or timeline updates are disclosed in the filing body.","Investors need to refer to the separate slide deck for pipeline details; no material metrics available here."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-042912","json":"https://secwatch.observer/filing/0001493152-24-042912.json","markdown":"https://secwatch.observer/filing/0001493152-24-042912.md","text":"https://secwatch.observer/filing/0001493152-24-042912.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000149315224042912/0001493152-24-042912-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000149315224042912/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:33:00.696504+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}